XML 62 R48.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Business Combination - Narratives (Details) $ in Millions |  | 12 Months Ended
--- | --- | ---
Jun. 01, 2016 USD ($) | Dec. 31, 2017 USD ($) | Dec. 31, 2016 USD ($)
Maximum |  |  |
Business combinations |  |  |
Potential future oncology development and regulatory approval milestone payments | $ 135.0 |  |
ARIAD |  |  |
Business combinations |  |  |
Upfront Payment | 147.5 |  |
Fair value of consideration transferred |  |  |
Fair value of consideration transferred | 440.5 |  |
Cash | 147.5 |  |
Contingent consideration | $ 293.0 |  |
ARIAD | Contingent Consideration |  |  |
Fair value of consideration transferred |  |  |
Probability of technical success (“PTS”) (as a percent) | 25.00% |  |
Projected cash flows period | 18 years |  |
ARIAD | Contingent Consideration | Discount rate |  |  |
Fair value of consideration transferred |  |  |
Discount rate (as a percent) | 10 |  |
ARIAD | Minimum |  |  |
Business combinations |  |  |
Royalties paid (as a percentage) | 32.00% |  |
ARIAD | Maximum |  |  |
Business combinations |  |  |
Royalties paid (as a percentage) | 50.00% |  |
Development costs |  | $ 7.0 | $ 7.0

X
- Definition Value of input used to measure contingent consideration liability from business combination. + References No definition available. + Details
Name: | incy_BusinessCombinationContingentConsiderationLiabilityMeasurementInput
Namespace Prefix: | incy_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition Period of time used to measure cash flows to find the present value of an amount to be paid or received in the future as an input to measure fair value. + References No definition available. + Details
Name: | incy_FairValueInputsCashFlowsEstimatedPeriod
Namespace Prefix: | incy_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of probability of technical success (“PTS”). + References No definition available. + Details
Name: | incy_FairValueInputsProbabilityOfTechnicalSuccess
Namespace Prefix: | incy_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents information pertaining to development cost paid. + References No definition available. + Details
Name: | incy_LicenseAgreementDevelopmentCostPaid
Namespace Prefix: | incy_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represents information pertaining to development cost paid. + References No definition available. + Details
Name: | incy_LicenseAgreementPercentageOfRoyaltiesToBePaid
Namespace Prefix: | incy_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents information pertaining to potential future oncology development and regulatory approval milestone payment. + References No definition available. + Details
Name: | incy_LicenseAgreementPotentialFutureOncologyDevelopmentAndRegulatoryApprovalMilestonePayments
Namespace Prefix: | incy_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represents information pertaining to upfront payments made under the share purchase agreement. + References No definition available. + Details
Name: | incy_SharePurchaseAgreementUpfrontPayment
Namespace Prefix: | incy_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 30 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477 + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationConsiderationTransferredAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of liability recognized arising from contingent consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 35 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6911338&loc=d3e6819-128478 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=incy_AriadPharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByLiabilityClassAxis=us-gaap_LiabilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | incy_MeasurementInputTypeAxis=incy_MeasurementInputDiscountRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |